“CORRELATION OF HISTOPATHOLOGICAL GRADING AND RADIOLOGICAL STAGING IN HEPATIC FIBROSIS: A CROSS-SECTIONAL STUDY USING ULTRASOUND ELASTOGRAPHY AND METAVIR SCORING”

Main Article Content

Amee Ashwinkumar Patel
Akshaykumar Sureshbhai Patel

Keywords

Hepatic fibrosis, METAVIR score, Ultrasound elastography, Liver stiffness, Chronic liver disease, Non-invasive fibrosis assessment.

Abstract

Background: Hepatic fibrosis is a progressive pathological condition associated with chronic liver disease, which can advance to cirrhosis and hepatocellular carcinoma if not diagnosed early. While liver biopsy remains the gold standard for staging fibrosis, it is invasive and carries procedural risks. Ultrasound elastography has emerged as a promising non-invasive modality for assessing liver stiffness, offering a potential alternative to histological examination.


Aim: To assess the correlation between radiological staging of hepatic fibrosis using ultrasound elastography and histopathological grading using the METAVIR scoring system.


Methods: A cross-sectional observational study was conducted at a tertiary care hospital in Vadodara, Gujarat, from November 2020 to November 2021. Sixty patients with chronic liver disease who underwent both liver biopsy and ultrasound elastography were included. Elastography values were measured in kilopascals (kPa), and histological grading was done using the METAVIR system. Statistical analysis was performed using Spearman’s rank correlation, ROC analysis, and diagnostic accuracy calculations.


Results: A strong positive correlation (r = 0.846, p < 0.001) was observed between elastography values and METAVIR scores. The optimal elastography cut-off of 7.1 kPa yielded 100% sensitivity and specificity for detecting significant fibrosis (≥F2). The area under the ROC curve (AUC) was 1.00, indicating excellent diagnostic performance. Substantial agreement was found between radiological and pathological staging (κ = 0.78).


Conclusion: Ultrasound elastography demonstrates excellent correlation with histopathological grading and can be a reliable, non-invasive tool for fibrosis staging in chronic liver disease. It may reduce the need for liver biopsy, especially in resource-limited settings, and improve early diagnosis and patient management.

Abstract 136 | PDF Downloads 47

References

1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008 Mar 8;371(9615):838–51.
2. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996 Aug;24(2):289–93.
3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000 Mar;31(3):481–4.
4. Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013 Aug;33(8):1138–47.
5. Ferraioli G, Tinelli C, Dal Bello B, et al. Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol. 2013 May 21;19(19):3006–14.
6. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 Jan;70(1):151–71.
7. Duseja A, Chalasani N. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) in India. Hepatol Int. 2013 Sep;7(Suppl 2):S575–85.
8. Madan K, Batra Y, Gupta SD, et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol. 2006 Nov 7;12(41):6552–7.
9. Patel M, Desai M, Baxi R, et al. Nonalcoholic fatty liver disease in urban population of Gujarat: A cross-sectional study. Int J Med Sci Public Health. 2016;5(12):2485–8.
10. Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011 Mar;5(2):625–34.
11. Joshi N, Chavda D, Panchal H. A study of liver stiffness measurements using transient elastography in patients of chronic liver disease and its correlation with liver biopsy in Gujarat. Gujarat Med J. 2020;75(2):15–21.
12. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960–974.
13. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48(5):835–847.
14. Madan K, Bhardwaj P, Thareja S, et al. Nonalcoholic fatty liver disease: Study of patients with diabetes and review of literature. J Assoc Physicians India. 2010;58:205–209.
15. Joshi N, Chavda D, Panchal H. A study of liver stiffness measurements using transient elastography in patients of chronic liver disease and its correlation with liver biopsy in Gujarat. Gujarat Med J. 2020;75(2):15–21.
16. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41(1):48–54.
17. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454–462.
18. Kim BK, Kim SU, Kim HS, et al. Prospective validation of FibroScan for the noninvasive assessment of hepatic fibrosis in Korean patients with chronic hepatitis B. Liver Int. 2010;30(4):546–553.
19. Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013;33(8):1138–1147.
20. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;31(3):481–484.
21. Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017;377(8):756–768.
22. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017–1044.